• Topotecan HCl: Mechanism, Evidence, and Workflow

  2026-08-12

  Topotecan HCl is a semisynthetic camptothecin analogue and topoisomerase 1 inhibitor that stabilizes the topoisomerase I-DNA complex. Preclinical evidence supports DNA damage and apoptosis induction in rapidly dividing tumor cells, while product-specific concentration, solubility, and storage parameters define practical assay design.

• Tomivosertib Calms Human DRG Hyperexcitability

  2026-08-12

  The reference study provides direct ex vivo evidence that MNK inhibition with tomivosertib rapidly and reversibly suppresses spontaneous activity in dorsal root ganglion neurons obtained from patients with radiculopathy. By linking electrophysiological changes to loss of eIF4E Ser209 phosphorylation, the work connects a defined signaling pathway with ectopic activity in human sensory neurons while also clarifying the limits of translating ex vivo findings into clinical treatment.

• DHEA: A Translational Bridge from Brain to Ovary

  2026-08-11

  Dehydroepiandrosterone (DHEA) is more than a steroid intermediate: it is a context-dependent research lever linking neuroprotection, apoptosis inhibition, neural stem cell biology, and ovarian inflammation. This article outlines how translational teams can use DHEA mechanistically, validate it across models, and avoid confusing disease induction with therapeutic benefit.

• Proteinase K: From Clean DNA to Mechanistic Insight

  2026-08-11

  A translational perspective on Proteinase K as both a high-performance DNA cleanup reagent and a carefully controlled tool for dissecting protein-dependent mechanisms in Candida albicans extracellular vesicle research.

• Mitoxantrone HCl: Applied Assay Workflows

  2026-08-10

  Mitoxantrone HCl combines DNA damage biology with a newly described route to ERα disruption, making it useful for apoptosis, viability, and endocrine-resistance studies. This workflow-focused guide covers formulation, dose finding, mechanistic controls, and troubleshooting across cancer and stem-cell models.

• TSPAN18–STIM1 Signaling in Prostate Cancer Bone Metastasis

  2026-08-09

  Zhou et al. identify TSPAN18 as a regulator of STIM1 stability and show that it promotes prostate cancer bone metastasis by preventing TRIM32-mediated ubiquitination of STIM1. The study connects a protein-stability mechanism with store-operated calcium entry, cancer-cell invasion, and clinical metastatic risk, providing a framework for investigating the TSPAN18–STIM1 axis in prostate cancer research.

• Norovirus Co-opts NINJ1 for Selective NS1 Secretion

  2026-08-08

  Song and colleagues show that murine norovirus exploits the membrane-rupture factor NINJ1 to release the viral protein NS1 through a regulated, cargo-selective pathway. The study combines genetic screening, cell biology, protein mutagenesis, and mouse infection models to connect caspase-3 activation, NINJ1 oligomerization, and suppression of intestinal antiviral immunity.

• Topotecan HCl: Smarter Cancer Assays

  2026-08-07

  Topotecan HCl is a topoisomerase 1 inhibitor whose assay response can reflect both growth arrest and cell killing. This guide translates Schwartz 2022 into practical strategies for separating DNA damage, apoptosis, and proliferation effects in cancer models.

• Technical Guide: Hoechst 33342/PI Double Staining Kit Protoc

  2026-08-07

  The Hoechst 33342/PI Double Staining Kit enables rapid, fluorescence-based discrimination of apoptotic and necrotic cells by targeting chromatin condensation and membrane integrity. It is best suited for basic research workflows using microscopy or similar detection methods, but is not intended for diagnostic or clinical applications.

• PP 1 Src Family Tyrosine Kinase Inhibitor: Applied Workflows

  2026-08-06

  PP 1 stands out as a selective Src family tyrosine kinase inhibitor, enabling precise modulation of oncogenic and immune signaling in cancer and immunology research. This article delivers actionable protocols, advanced applications, and troubleshooting strategies to maximize the translational value of PP 1, contextualized by recent breakthroughs in biomarker-driven cancer therapies.

• HyperScript™ Reverse Transcriptase: Precision cDNA Synthesis

  2026-08-06

  HyperScript™ Reverse Transcriptase enables robust cDNA synthesis from challenging, structured, or low-abundance RNA—empowering transcriptome analyses where conventional enzymes fall short. Its enhanced thermal stability and affinity maximize yield and fidelity, making it a benchmark tool for quantitative molecular workflows.

• Hypoxia and Immunometabolism in Tumor Microenvironments

  2026-08-05

  This review elucidates how hypoxia-driven metabolic reprogramming and immune metabolism collectively shape the tumor microenvironment (TME), enabling tumor progression and immune evasion. The work emphasizes the mechanistic interplay between oxygen deprivation, glucose utilization, and immune cell function, providing a foundation for developing metabolism-based cancer therapies.

• BMP4-GPX4 Axis Modulates Ferroptosis in Glaucoma Stem Cell T

  2026-08-05

  This study reveals that enhancing BMP4-GPX4 signaling in mouse models of glaucoma reduces ferroptosis and supports retinal ganglion cell survival after stem cell transplantation. The findings propose a targeted molecular approach to improve neuroprotection and differentiation in high intraocular pressure glaucoma.

• PPM-18: Precision iNOS Inhibition for Inflammation Research

  2026-08-04

  PPM-18 offers targeted iNOS expression inhibition via NF-κB pathway blockade, enabling reproducible inflammation and sepsis model workflows. This guide delivers actionable protocol enhancements, troubleshooting strategies, and cross-study insights to maximize the impact of PPM-18 in translational immune modulation.

• Stat3 and NF-κB Mediate Fyn-Driven Dopaminergic Neurodegener

  2026-08-04

  This study establishes that constitutive activation of Fyn kinase in zebrafish neurons leads to dopaminergic neuron loss and microglial inflammation via Stat3 and NF-κB pathways. The findings clarify key mechanistic links relevant to Parkinson’s disease and highlight new avenues for targeted intervention in neurodegeneration models.

578 records 10/39 page Previous Next First page 上5页 678910 下5页 Last page